116 related articles for article (PubMed ID: 25656881)
1. Drug combo beneficial in colorectal cancer.
Cancer Discov; 2015 Feb; 5(2):102. PubMed ID: 25656881
[No Abstract] [Full Text] [Related]
2. A Phase Ib Dose-Escalation Study of Encorafenib and Cetuximab with or without Alpelisib in Metastatic
van Geel RMJM; Tabernero J; Elez E; Bendell JC; Spreafico A; Schuler M; Yoshino T; Delord JP; Yamada Y; Lolkema MP; Faris JE; Eskens FALM; Sharma S; Yaeger R; Lenz HJ; Wainberg ZA; Avsar E; Chatterjee A; Jaeger S; Tan E; Maharry K; Demuth T; Schellens JHM
Cancer Discov; 2017 Jun; 7(6):610-619. PubMed ID: 28363909
[TBL] [Abstract][Full Text] [Related]
3. Encorafenib (Braftovi) for metastatic colorectal cancer.
Med Lett Drugs Ther; 2021 Jan; 63(1616):15-16. PubMed ID: 33512348
[No Abstract] [Full Text] [Related]
4. Cetuximab for metastatic colorectal cancer.
Garattini S; Torri V; Floriani I
N Engl J Med; 2009 Jul; 361(1):96; author reply 96-7. PubMed ID: 19579281
[No Abstract] [Full Text] [Related]
5. Drug Combo Beats Vemurafenib Alone for Colorectal Cancer.
Cancer Discov; 2017 Mar; 7(3):242. PubMed ID: 28153858
[TBL] [Abstract][Full Text] [Related]
6. Exploring better strategies for EGFR antibodies in colon cancer.
Cervantes A
Lancet Oncol; 2014 May; 15(6):549-50. PubMed ID: 24703530
[No Abstract] [Full Text] [Related]
7. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Copur MS; Norvell M; Obermiller A
N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445033
[No Abstract] [Full Text] [Related]
8. Cetuximab or bevacizumab in metastatic colorectal cancer?
Sclafani F; Cunningham D
Lancet Oncol; 2014 Sep; 15(10):1040-1. PubMed ID: 25088941
[No Abstract] [Full Text] [Related]
9. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Frati L; Codacci-Pisanelli G
N Engl J Med; 2009 May; 360(20):2134-5; author reply 2135-6. PubMed ID: 19445031
[No Abstract] [Full Text] [Related]
10. Cetuximab in colon cancer.
Costa AF; Sander GB; Picon PD
N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15473024
[No Abstract] [Full Text] [Related]
11. K-Ras mutations are changing practice in advanced colorectal cancer.
McNeil C
J Natl Cancer Inst; 2008 Dec; 100(23):1667-9. PubMed ID: 19033564
[No Abstract] [Full Text] [Related]
12. Cetuximab in colon cancer.
Martin MJ
N Engl J Med; 2004 Oct; 351(15):1575-6; author reply 1575-6. PubMed ID: 15473023
[No Abstract] [Full Text] [Related]
13. Can the addition of cetuximab to irinotecan improve outcome in colorectal cancer?
Saltz LB
Nat Clin Pract Oncol; 2005 Jan; 2(1):20-1. PubMed ID: 16264850
[No Abstract] [Full Text] [Related]
14. [Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer].
Soda H; Nemoto H; Akatsuka S; Arioka H; Shimada K; Ito T; Takinishi Y; Egawa M; Nagashima A; Kenmochi T; Sasaki T; Azuma T; Koizumi W; Hibi K
Gan To Kagaku Ryoho; 2013 May; 40(5):605-8. PubMed ID: 23863582
[TBL] [Abstract][Full Text] [Related]
15. New combinations in metastatic colorectal cancer: what are our expectations?
Hurwitz H
Oncologist; 2005 May; 10(5):320-2. PubMed ID: 15851788
[No Abstract] [Full Text] [Related]
16. Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer.
Weickhardt AJ; Price TJ; Chong G; Gebski V; Pavlakis N; Johns TG; Azad A; Skrinos E; Fluck K; Dobrovic A; Salemi R; Scott AM; Mariadason JM; Tebbutt NC
J Clin Oncol; 2012 May; 30(13):1505-12. PubMed ID: 22412142
[TBL] [Abstract][Full Text] [Related]
17. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.
Siu LL; Shapiro JD; Jonker DJ; Karapetis CS; Zalcberg JR; Simes J; Couture F; Moore MJ; Price TJ; Siddiqui J; Nott LM; Charpentier D; Liauw W; Sawyer MB; Jefford M; Magoski NM; Haydon A; Walters I; Ringash J; Tu D; O'Callaghan CJ
J Clin Oncol; 2013 Jul; 31(19):2477-84. PubMed ID: 23690424
[TBL] [Abstract][Full Text] [Related]
18. Always look at the bright side of drugs?
Nygren P
Acta Oncol; 2015 Feb; 54(2):145-7. PubMed ID: 25608927
[No Abstract] [Full Text] [Related]
19. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Loupakis F; Di Maio M; Falcone A
N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445032
[No Abstract] [Full Text] [Related]
20. Adjuvant therapy after hepatectomy for colorectal metastases.
Fong Y
Lancet Oncol; 2014 May; 15(6):544-5. PubMed ID: 24807857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
